Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by Ducksoup000001on Feb 16, 2017 2:05pm
156 Views
Post# 25856604

RE:Gain on biologicals explained by example.

RE:Gain on biologicals explained by example. Good post. It echoes well to my last post that Quarterly reported large inventory is an issue. And I cannot put myself to understand how the next quarter will be a big hit. 


GoBlue2016 wrote:
 
CGC Lemonade Stand 3Q F2017. (In $000's)
 
Dad:  Hey son. How's the lemonade business?  
 
Son: pretty good Dad. I sold $9,752. 
 
Dad: Wow! That's pretty good. What did you make?
 
Son: Well, the lemons, sugar and water and other production costs (cost of goods sold) were $10,950. 
 
Dad: So you lost $1,198?
 
Son: Well no. You see I picked some more lemons (harvest). 
 
Dad: How does that make any difference?
 
Son: My accountant says I get to add back the value of what I grew during the period after Harvest (non cash gain on biologicals) even though I didn't sell it. 
 
Dad: How much did you grow and not sell?
 
Son: $18,141. 
 
Dad: So how much does the accountant say you made?
 
Son: $16,493 (gross profit), crazy eh? Especially given my sales were only $9,752. 
 
Dad: How much inventory do you now have?
 
Son: $50,958. 
 
(Dad Opens garage and is confronted by boxes - floor to ceiling - of lemons) 
 
Dad: Son, how many lemons are in here?
 
Son: if I sell at the same pace as last quarter ... 15 months.  If I double my sales 7.5 months. But don't worry I have a HUGE harvest tomorrow too.  
 
NOTE: I do not have a short position in WEED.   
 
Their YTD loss is $36.4 million (MORE THAN THEIR SALES) when you back out accounting shenanigans. 
 
When life gives you lemons...


Bullboard Posts